A New Decade Of Outsourcing: What Can We Expect?
Will the "Twenty-Twenties" be as exciting as they sound for our industry? For certain, nobody saw a coronavirus outbreak put outsourcing in such a public light.
Outsourced Pharma hosted a live, virtual discussion in June 2020 focusing on four key areas: continuous manufacturing; cell and gene therapy influences; new sponsor-CDMO service models; and "Supply Chain 4.0."
Our esteemed panel included Darren Dasburg, (former) VP & Head Learning and Development Global Operations | AstraZeneca, Shawn Eisenberg, Executive Director, Manufacturing & Supply Chain | ImmunoGen, Praveen Prasanna, Sr. Director, Technical Operations | AVEO Oncology, Jana Spes, Head of Pharmaceutical Development & Manufacturing Sciences | Ironwood Pharmaceuticals, and Mark Butchko, Sr. Director, Quality Assurance - Development | Lilly and Company.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.